AssetMark Inc’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67M | Buy |
|
|||||
|
2025
Q1 | $65.7M | Buy |
|
|||||
|
2024
Q4 | $71.9M | Sell |
|
|||||
|
2024
Q3 | $109M | Buy |
|
|||||
|
2024
Q2 | $101M | Buy |
|
|||||
|
2024
Q1 | $90.6M | Buy |
|
|||||
|
2023
Q4 | $81M | Buy |
|
|||||
|
2023
Q3 | $74.6M | Buy |
|
|||||
|
2023
Q2 | $57.9M | Buy |
|
|||||
|
2023
Q1 | $61.7M | Buy |
|
|||||
|
2022
Q4 | $50.4M | Buy |
|
|||||
|
2022
Q3 | $46.3M | Sell |
|
|||||
|
2022
Q2 | $40.1M | Sell |
|
|||||
|
2022
Q1 | $50.9M | Buy |
|
|||||
|
2021
Q4 | $39.1M | Buy |
|
|||||
|
2021
Q3 | $36.3M | Sell |
|
|||||
|
2021
Q2 | $34M | Sell |
|
|||||
|
2021
Q1 | $29.9M | Buy |
|
|||||
|
2020
Q4 | $27.8M | Buy |
|
|||||
|
2020
Q3 | $17.9M | Buy |
|
|||||
|
2020
Q2 | $715K | Buy |
|
|||||
|
2020
Q1 | $21K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.08M | Buy |
|
|||||
|
2019
Q2 | $6K | Sell |
|
|||||
|
2019
Q1 | $86K | Sell |
|
|||||
|
2018
Q4 | $99K | Buy |
|
|||||
|
2018
Q3 | $94K | Buy |
|
|||||
|
2018
Q2 | $27K | Buy |
|
|||||
|
2018
Q1 | $22K | Sell |
|
|||||
|
2017
Q4 | $34K | Buy |
|
|||||
|
2017
Q3 | $27K | Buy |
|
|||||
|
2017
Q2 | $27K | Sell |
|
|||||
|
2017
Q1 | $23K | Buy |
|
|||||
|
2016
Q4 | $17K | Buy |
|
|||||
|
2016
Q3 | $18K | Buy |
|
|||||
|
2016
Q2 | $12K | Sell |
|
|||||
|
2016
Q1 | $22K | Buy |
|
|||||
|
2015
Q4 | $12K | Buy |
|
|||||
|
2015
Q3 | $3K | Hold |
|
|||||
|
2015
Q2 | $4K | Buy |
|